✦ LIBER ✦

Decreased incidence of viral infections in liver transplant recipients

✍ Scribed by Nina Singh; Luis Mieles; Victor L. Yu; Thomas E. Starzl

Book ID: 112691724
Publisher: Springer US
Year: 1994
Tongue: English
Weight: 504 KB
Volume: 39
Category: Article
ISSN: 0163-2116
DOI: 10.1007/bf02090054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non viral infection and colonisation in

Non viral infection and colonisation in liver transplant recipients

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Respiratory Viral Infections in Renal Tr

Respiratory Viral Infections in Renal Transplant Recipients

✍ Mauro Jose Costa Salles; Yvoty Alves dos Santos Sens; Lucy Villas Boas; Clarisse 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Fungal infections in liver transplant re

Fungal infections in liver transplant recipients

✍ O. Grauhan; R. Lohmann; P. Lemmens; N. Schattenfroh; H. Keck; E. Klein; R. Raako 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 922 KB

Quantitative EBV Viral Loads and Immunos

Quantitative EBV Viral Loads and Immunosuppression Alterations can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients

✍ Timothy C. Lee; Barbara Savoldo; Cliona M. Rooney; Helen E. Heslop; Adrian P. Ge 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

P609 - Increased incidence of viral hepa

P609 - Increased incidence of viral hepatitis in HLA compatible liver transplant recipients

✍ Rene J. Duquesnoy; Rafael Manez; Anthony J. Demetris 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Effect of sirolimus on infection inciden

Effect of sirolimus on infection incidence in liver transplant recipients

✍ Adrian Fisher; Joseph M. Seguel; Andrew N. de la Torre; Dorian Wilson; Anand Mer 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Sirolimus is a new immunosuppressive agent that lacks the nephrotoxicity and neurotoxicity associated with calcineurin inhibitors. [1][2][3] The addition of sirolimus to immunosuppressive protocols may thus allow sparing of calcineurin inhibitors and reduction or elimination of associated toxicities